These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2466112)

  • 21. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An improved system for quantifying AgNOR and PCNA in canine tumors.
    Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
    Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
    Smith FG; Murray PG; Crocker J
    J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL].
    Cosimi MF; Casagranda I; Porta C; Moroni M; Orsi R; Nastasi G
    Sangre (Barc); 1992 Oct; 37(5):399-402. PubMed ID: 1293782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleolar ultrastructure in low- and high-grade non-Hodgkin's lymphomas.
    Goodlad JR; Crocker J; Mccartney JC
    J Pathol; 1991 Mar; 163(3):233-7. PubMed ID: 2013826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nucleolar organizer regions and mitotic activity in non-Hodgkin's lymphoma].
    Dubrovskiĭ ACh; Kliukina LB
    Arkh Patol; 1997; 59(1):25-30. PubMed ID: 9139602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semi-automatic quantitation of nucleolar organizer regions in non-Hodgkin's lymphomas.
    Kalir T; Chan KS; Liu Z; Strauchen J; Gil J
    Pathol Res Pract; 1994 Feb; 190(2):124-8. PubMed ID: 7520162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
    Babu M; Mathur M; Gupta SD; Chattopadhyay TK
    Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of staining of nucleolar organizer regions in cytological smears of the bronchus.
    Huang MS; Hwang JJ; Tsai MS; Wang TH; Lin MS; Chong IW; Tsai SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Mar; 8(3):136-40. PubMed ID: 1373195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach.
    Kakeji Y; Maehara Y; Orita H; Emi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
    J Am Coll Surg; 1996 Jun; 182(6):482-7. PubMed ID: 8646347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AgNOR quantification with special reference to staining patterns.
    Rüschoff J; Fauser G; Knüchel R; Hofstädter F
    Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential demonstration of nucleolar organizer regions and Ki67 immunolabelling in non-Hodgkin's lymphomas.
    Janmohamed RM; Murray PG; Crocker J; Leyland MJ
    Clin Lab Haematol; 1990; 12(4):395-9. PubMed ID: 2081380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.